Inovia Capital raises $600m venture funds

Inovia Capital, the Canadian VC firm, has raised two new funds totalling US$600 million: an early-stage fund of $200 million; and a growth-stage of $400 million. The funds will be invested in its existing markets in Canada and Silicon Valley, as well as through a new office in London.

Vicarious Surgical raises $10m for product development

Vicarious Surgical, a company working on minimally-invasive surgery, has raised a further $10 million from Gates Frontier, Khosla Ventures, Innovation Endeavours, AME Cloud Ventures, and Marc Benioff.

HIMSS19 focus on value-based care

At HIMSS19, one theme seems to filter through all the buzz and activity: delivering value-based, patient-centred care.

OneTouch blood glucose monitoring study demonstrates accuracy

The OneTouch Select Plus blood glucose monitoring system is the subject of a long-term study published this week in the Journal of Diabetes Science and Technology (JDST), and demonstrates the accuracy of its readings.

DNAnexus raises $68 million to develop multiomics platform

DNAnexus, the bioinformatics company, has closed a $68 million financing round from a combination of existing investors, including GV, Foresite Capital, TPG Biotech, WuXi NextCODE and Claremont Creek Ventures, and debt and equity from Innovatus Capital Partners.